Precision Medicine Applications in Oncology Webinar Series
Driven by the increased emphasis on precision and personalized approaches to drug development, Covance will be delivering a webinar series to look at specific challenges and opportunities with current and future applications in oncology.
The series kicks off with a view of trends in immunotherapies including preclinical model selection, biomarkers of safety and efficacy, and specific trial design and medical monitoring considerations.
Other topics delve into:
- Adoptive T-cell therapies, addressing safety assessment and monitoring tools from preclinical through clinical development
- Considerations for clinical trial design and execution for novel targeted therapies and immunotherapies
- Biomarker technologies for the detection of rare cancer driver mutations and novel targeted therapies
- Applications for liquid biopsy technologies
Tumor Model Spotlights
- Preclinical Oncology: 2020 Spotlight Roundup
- CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies
- Determining preclinical CAR T-cell persistence by flow cytometry
- Pan02-Luc: An orthotopic model of pancreatic cancer
- Bioluminescence imaging: In vivo monitoring of tumor development, disease dissemination and treatment efficacy
- 5TGM1-luc – A syngeneic murine model for multiple myeloma
- Functional Analysis of Tumor Infiltrating Lymphocytes by Flow Cytometry Using the Cytokine/Cytotoxicity™ Panel
- Update on the preclinical use of hPBMC for immuno-oncology modeling